Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Prichard

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic Chemistry|February 3, 2007
Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analoguesXinying Zhang, Adel Amer, Xuesen Fan, et al.
The Journal of Infectious Diseases|March 6, 2020
Advances in the Development of Therapeutics for Cytomegalovirus InfectionsEdward Acosta, Terry Bowlin, Jennifer Brooks, et al.
Antiviral Research|September 16, 2021
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challengeScott Parker, June D'Angelo, R Mark Buller, et al.
Natural Product Research|December 8, 2020
Allobetulone rearrangement to l8αH,19βH-ursane triterpenoids with antiviral activityMarat Babaev, Elmira Khusnutdinova, Alexander Lobov, et al.
Molecular Therapy Oncolytics|March 28, 2017
Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human PrimatesKevin A Cassady, David F Bauer, Justin Roth, et al.
Journal of Virology|January 8, 2016
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesEve-Isabelle Pécheur, Viktoriya Borisevich, Peter Halfmann, et al.
The Journal of Infectious Diseases|April 19, 2006
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccinesThomas C Heineman, Mark Schleiss, David I Bernstein, et al.
Transfusion|April 16, 2011
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kineticsJie Li, Ellie Hamilton, Louette Vaughn, et al.
Science (New York, N.Y.)|July 21, 2007
Host immune system gene targeting by a viral miRNANoam Stern-Ginossar, Naama Elefant, Albert Zimmermann, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic Chemistry|February 3, 2007
Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analoguesXinying Zhang, Adel Amer, Xuesen Fan, et al.
The Journal of Infectious Diseases|March 6, 2020
Advances in the Development of Therapeutics for Cytomegalovirus InfectionsEdward Acosta, Terry Bowlin, Jennifer Brooks, et al.
Antiviral Research|September 16, 2021
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challengeScott Parker, June D'Angelo, R Mark Buller, et al.
Natural Product Research|December 8, 2020
Allobetulone rearrangement to l8αH,19βH-ursane triterpenoids with antiviral activityMarat Babaev, Elmira Khusnutdinova, Alexander Lobov, et al.
Molecular Therapy Oncolytics|March 28, 2017
Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human PrimatesKevin A Cassady, David F Bauer, Justin Roth, et al.
Journal of Virology|January 8, 2016
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesEve-Isabelle Pécheur, Viktoriya Borisevich, Peter Halfmann, et al.
The Journal of Infectious Diseases|April 19, 2006
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccinesThomas C Heineman, Mark Schleiss, David I Bernstein, et al.
Transfusion|April 16, 2011
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kineticsJie Li, Ellie Hamilton, Louette Vaughn, et al.
Science (New York, N.Y.)|July 21, 2007
Host immune system gene targeting by a viral miRNANoam Stern-Ginossar, Naama Elefant, Albert Zimmermann, et al.
Scientific Reports|January 13, 2021
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activityEvelyn M Covés-Datson, Steven R King, Maureen Legendre, et al.
Pageof 3